Records containing: Retinal Vein Occlusion
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-09-06RETRO CRVO: Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion
-
CLINICAL_TRIALS study record update · 2018-08-31Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap
-
CLINICAL_TRIALS study record update · 2018-08-29Phase 2 Ziv-aflibercept in Ocular Disease Short and Long-term Study
-
CLINICAL_TRIALS study record update · 2018-06-27Phase 2a Open Label Study to Assess the Efficacy and Safety of Subcutaneous 15mg AKB-9778 Administered Twice Daily for 84 Days in Subjects With Retinal Vein Occlusion
-
CLINICAL_TRIALS study record update · 2018-04-06Correlation Between the Visual Acuity and the OCT Pattern of Macular Edema Secondary to Retinal Vein Occlusion
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-01-05Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients.
-
CLINICAL_TRIALS study record update · 2017-10-30Posterior Vitreous Detachment (PVD) Assessment During Dual RVO Lucentis Evaluations (PADDLE Study)
-
CLINICAL_TRIALS study record update · 2017-10-27Comparison of Anti-vascular Endothelial Growth Factors Agents in the Treatment of Macular Edema Following Retinal Vein Occlusion
-
CLINICAL_TRIALS study record update · 2017-08-14A Phase I Open Label Study of the Safety, Tolerability and Efficacy of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)
-
CLINICAL_TRIALS study record update · 2017-07-25Intravitreal Injection Using 33-gauge Versus 30-gauge Needles: Comparison of Patients' Experience
-
CLINICAL_TRIALS study record update · 2017-07-02Phase I Study of Intravitreal Injections Versus Anterior Sub-Tenon Injections of Triamcinolone Acetonide Formulation for Macular Edema in Retinal Disorders
-
CLINICAL_TRIALS study record update · 2017-07-02Pilot Study of Intravitreal Injection of Triamcinolone Acetonide Formulation for Retinal Vascular Disorders
-
CLINICAL_TRIALS study record update · 2017-05-31Efficacy of an Intravitreal Dexamethasone Implant on Macular Function in Retinal Vein Occlusion Following Treatment With Intravitreal Anti-VEGF Injections.
-
CLINICAL_TRIALS study record update · 2017-02-01A Safety and Efficacy Study to Assess DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)
-
CLINICAL_TRIALS study record update · 2016-11-18A 3-month, Phase III, Open-label, Single Arm, Multicenter Study Assessing the Efficacy and Safety of 0.5 mg Ranibizumab Monthly Intravitreal Injections as Monotherapy in Patients With Visual Impairment Due to Macular Edema Secondary to Branch or Central Retinal Vein Occlusion (RVO)
-
CLINICAL_TRIALS study record update · 2016-09-29An Open-label, Nonrandomized, Phase IIIb, Single Dose Study to Evaluated the Changes in Optical Coherence Tomography (OCT) and Fluorescein Angiography (FA) After Intravitreal Injection of Lucentis® in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)
-
CLINICAL_TRIALS study record update · 2016-07-21ClinicalTrials.gov study NCT01903720
-
CLINICAL_TRIALS study record update · 2016-06-01Prospective Study on Antimicrobial Resistance Rates Following Repeated Courses of Topical Antibiotics for Intravitreal Injection
-
CLINICAL_TRIALS study record update · 2016-05-26ClinicalTrials.gov study NCT01918371
-
CLINICAL_TRIALS study record update · 2016-05-23LUMINOUS: Study to Observe the Effectiveness and Safety of Ranibizumab Through Individualized Patient Treatment and Associated Outcomes
-
CLINICAL_TRIALS study record update · 2016-05-19Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients With Neovascular Age-related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2016-05-17An Open-label, Multi-center, 6-month Extension Study Comparing the Long-term Efficacy and Safety of Lucentis (Ranibizumab) Intravitreal Injections Versus Ozurdex (Dexamethasone) Intravitreal Implant in Patients With Visual Impairment Due to Macular Edema Following Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO) Who Have Completed the Respective Core Study (CRFB002EDE17 or CRFB002EDE18)
-
CLINICAL_TRIALS study record update · 2016-04-20ClinicalTrials.gov study NCT01539577
-
CLINICAL_TRIALS study record update · 2016-03-15RanibizumabDosE Comparison (0.5mg and 2.0mg) and the Role of LAser in the ManagemenT of REtinal Vein Occlusion - A Pharmacodynamic Approach(RELATE)
-
CLINICAL_TRIALS study record update · 2016-02-15ClinicalTrials.gov study NCT01427751